Given the important role of visceral adipose tissue dysfunction in MASLD/MASH development (Gastaldelli and Cusi, 2019), Gremlin-1 could drive the development and progression of MASH by modulating local adipose tissue function. This evidence concerns the gene GREM1 and metabolic dysfunction-associated steatotic liver disease.